Another potential exosomal biomarker present in the course of T2D is cystatin C, which positively correlates with metabolic complications of obesity such as myocardial infarction, vascular disease mortality, subsequent vascular events, and metabolic syndrome [80,81]. Here, CST3 is linked to type 2 diabetes mellitus.